Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,838 | 758 | 914 | 0 | N/A |
| Receivables | 600 | N/A | N/A | 0 | N/A |
| Other current assets | 247 | 0 | 0 | 0 | 0 |
| TOTAL | $20,685 | $964 | $1,181 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 693 | N/A | N/A | N/A | N/A |
| Investments And Advances | 0 | 100,355 | 100,416 | 0 | 0 |
| Other Non-Current Assets | 1,979 | 0 | 0 | 0 | 0 |
| TOTAL | $2,672 | $100,355 | $100,416 | $N/A | $N/A |
| Total Assets | $23,357 | $101,318 | $101,597 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,417 | 172 | 185 | 0 | 0 |
| Accrued Expenses | 2,595 | N/A | N/A | 0 | N/A |
| TOTAL | $4,012 | $180 | $258 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 54,475 | 96,138 | 96,339 | 0 | 0 |
| TOTAL | $54,475 | $96,138 | $96,339 | $N/A | $N/A |
| Total Liabilities | $58,487 | $96,318 | $96,597 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,250 | 1,250 | 1,250 | N/A | N/A |
| Common Shares | 1 | 0 | 0 | 0 | N/A |
| Retained earnings | -36,813 | -442 | -241 | 0 | N/A |
| TOTAL | $-35,130 | $5,000 | $5,000 | $0 | $N/A |
| Total Liabilities And Equity | $23,357 | $101,318 | $101,597 | $0 | $0 |